ArticleCardiology journal2021
Kardia Mobile applicability in clinical practice: A comparison of Kardia Mobile and standard 12-lead electrocardiogram records in 100 consecutive patients of a tertiary cardiovascular care center.
Article in Cardiology journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06974006 (Integrated Monitoring for Independent Living in Rural Settings), which is not on this map. Cited by 35 papers, 5 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Integrated Monitoring for Independent Living in Rural Settings
Who cites it
35 citing papers in PubMed, 5 syntheses or guidelines pooled it.
- KardiaMobile 6L for measuring QT interval in people having antipsychotic medication to inform early value assessment: a systematic review.Health technology assessment (Winchester, England) · 2024Pooled it
- 2021 ISHNE/ HRS/ EHRA/ APHRS collaborative statement on mHealth in Arrhythmia Management: Digital Medical Tools for Heart Rhythm Professionals: From the International Society for Holter and Noninvasive Electrocardiology/Heart Rhythm Society/European Heart Rhythm Association/Asia Pacific Heart Rhythm Society.Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc · 2021Guideline
- HRS/EHRA/APHRS/LAHRS/ACC/AHA Worldwide Practice Update for Telehealth and Arrhythmia Monitoring During and After a Pandemic.Journal of the American College of Cardiology · 2020Guideline
- HRS/EHRA/APHRS/LAHRS/ACC/AHA worldwide practice update for telehealth and arrhythmia monitoring during and after a pandemic.Heart rhythm · 2020Guideline
- Accuracy of mHealth Devices for Atrial Fibrillation Screening: Systematic Review.JMIR mHealth and uHealth · 2019Pooled it
- A mobile relational agent to enhance atrial fibrillation self-care: Primary and secondary outcomes of a randomized controlled trial.American heart journal · 2025Trial
- Wearables for Telemonitoring in ATTR-Amyloidosis: Current Perspectives.Sensors (Basel, Switzerland) · 2026Review
- Wearable and Portable Electrocardiographic Devices as Modern Cardiac Telemetry Solutions in Pediatrics: A Systematic Review.Journal of clinical medicine · 2026Review
- Integrating mHealth Innovations into Decentralized Oncology Trials.Journal of medical systems · 2025Review
- A Pilot Study of the Home-Based 12-Lead Electrocardiogram in Clinical Practice.Mayo Clinic proceedings. Innovations, quality & outcomes · 2025Article
- Six-Lead Electrocardiography Enables Identification of Rhythm and Conduction Anomalies of Patients in the Telemedicine-Based, Hospital-at-Home Setting: A Prospective Validation Study.Sensors (Basel, Switzerland) · 2023Article
- Corrected QT Interval (QTc) Diagnostic App for the Oncological Routine: Development Study.JMIR cardio · 2023Article
- Electrocardiogram Devices for Home Use: Technological and Clinical Scoping Review.JMIR cardio · 2023Article
- Personalized LSTM Models for ECG Lead Transformations Led to Fewer Diagnostic Errors Than Generalized Models: Deriving 12-Lead ECG from Lead II, V2, and V6.Sensors (Basel, Switzerland) · 2023Article
- Smart devices to measure and monitor QT intervals.Frontiers in cardiovascular medicine · 2023Review
- Article
- [Application of wearable 12-lead electrocardiogram devices in pre-hospital diagnosis of acute ST segment elevation myocardial infarction].Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2022Article
- Monitoring prolongation of QT interval in patients with multidrug-resistant tuberculosis and non-tuberculous mycobacterium using mobile health device AliveCor.Journal of clinical tuberculosis and other mycobacterial diseases · 2022Article
- Mobile Single-Lead Electrocardiogram Technology for Atrial Fibrillation Detection in Acute Ischemic Stroke Patients.Journal of clinical medicine · 2022Article
- NICE atrial fibrillation guideline snubs wearable technology: a missed opportunity?Clinical medicine (London, England) · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMobile devices are gaining a rising number of users in all countries around the globe. Novel solutions to diagnose patients with out-of-hospital onset of arrhythmic symptoms can be easily used to record such events, but the effectiveness of these devices remain unknown.
methodsIn a group of 100 consecutive patients of an academic cardiology care center (mean age 68 ± 14.2 years, males: 66%) a standard 12-lead electrocardiogram (ECG) and a Kardia Mobile (KM) record were registered. Both versions were assessed by three independant groups of physicians.
resultsThe analysis of comparisons for standard ECG and KM records showed that the latter is of lower quality (p < 0.001). It was non-inferior for detection of atrial fibrillation and atrial flutter, showed weaker rhythm detection in pacemaker stimulation (p = 0.008), and was superior in sinus rhythm detection (p = 0.02), though. The sensitivity of KM to detect pathological Q-wave was low compared to specificity (20.6% vs. 93.7%, respectively, p < 0.001). Basic intervals measured by the KM device, namely PQ, RR, and QT were significantly different (shorter) than those observed in the standard ECG method (160 ms vs. 180 ms [p < 0.001], 853 ms vs. 880 ms [p = 0.03] and 393 ms vs. 400 ms [p < 0.001], respectively).
conclusionsInitial and indicative value of atrial fibrillation and atrial flutter detection in KM is comparable to results achieved in standard ECG. KM was superior in detection of sinus rhythm than eye-ball evaluation of 12-lead ECG. Though, the PQ and QT intervals were shorter in KM as compared to 12-lead ECG. Clinical value needs to be verified in large studies, though.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.